We are live on ! Find out more
DTIL icon

Precision BioSciences
DTIL

115 hedge funds and large institutions have $211M invested in Precision BioSciences in 2020 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 49 increasing their positions, 23 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 23

38% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 16

33% more capital invested

Capital invested by funds: $159M → $211M (+$52M)

6% more funds holding

Funds holding: 109 → 115 (+6)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0.07% less ownership

Funds ownership: 1.7% → 1.63% (-0.07%)

46% less call options, than puts

Call options by funds: $412K | Put options by funds: $769K

Holders
115
Holders Change
+6
Holders Change %
+5.5%
% of All Funds
2.36%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
22
Increased
49
Reduced
23
Closed
16
Calls
$412K
Puts
$769K
Net Calls
-$357K
Net Calls Change
-$206K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$5.26M
2
Millennium Management
Millennium Management
New York
+$3.84M
3
ACH
ArrowMark Colorado Holdings
Colorado
+$2.34M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.84M
5
SCM
Sio Capital Management
New York
+$1.35M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$8.91M
2
VP
venBio Partners
California
-$8.88M
3
Victory Capital Management
Victory Capital Management
Texas
-$7.14M
4
B
Bailard
California
-$1.67M
5
JP Morgan Chase
JP Morgan Chase
New York
-$1.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
Capital World Investors
1
Capital World Investors
California
$33.8M – – –
BlackRock
2
BlackRock
New York
$26.3M +$5.26M +24,003 +30%
VP
3
venBio Partners
California
$23.3M -$8.88M -40,544 -30%
ACH
4
ArrowMark Colorado Holdings
Colorado
$18.9M +$2.34M +10,689 +17%
Vanguard Group
5
Vanguard Group
Pennsylvania
$13.7M +$1.84M +8,386 +18%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$10.2M -$8.91M -40,687 -50%
Franklin Resources
7
Franklin Resources
California
$8.52M -$562K -2,566 -7%
CA
8
CHI Advisors
New York
$8M +$142K +649 +2%
State Street
9
State Street
Massachusetts
$6.35M +$1.17M +5,335 +27%
Millennium Management
10
Millennium Management
New York
$5.75M +$3.84M +17,523 +321%
ACWM
11
Adams Chetwood Wealth Management
North Carolina
$4.46M -$292K -1,333 -7%
Northern Trust
12
Northern Trust
Illinois
$4.04M +$889K +4,060 +33%
WMSA
13
Weiss Multi-Strategy Advisers
New York
$3.87M +$815K +3,723 +32%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$3.25M +$541K +2,469 +23%
Principal Financial Group
15
Principal Financial Group
Iowa
$2.99M +$942K +4,303 +56%
CAM
16
Cormorant Asset Management
Massachusetts
$2.89M – – –
LCM
17
Laurion Capital Management
New York
$1.89M – – –
N
18
Nuveen
North Carolina
$1.7M +$139K +633 +10%
Victory Capital Management
19
Victory Capital Management
Texas
$1.63M -$7.14M -32,597 -83%
SCM
20
Sio Capital Management
New York
$1.54M +$1.35M +6,168 New
Bank of New York Mellon
21
Bank of New York Mellon
New York
$1.36M +$469K +2,143 +65%
MSAM
22
Moloney Securities Asset Management
Missouri
$1.3M +$325K +1,485 +40%
NNP
23
Nachman Norwood & Parrott
South Carolina
$1.19M +$4.6K +21 +0.4%
VC
24
Vivo Capital
California
$1.17M – – –
Goldman Sachs
25
Goldman Sachs
New York
$1.1M +$724K +3,305 +297%
1
2 3 4 5

DTIL Hedge Fund Activity: Q2 2020 in Review

115 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q2 2020, worth a combined $211M — up 33% from $159M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new DTIL positions and 16 closed out — a net gain of 6 holders — while 49 added to existing stakes and 23 trimmed.

The largest buyer was BlackRock, adding an estimated $5.26M. The largest seller was Fidelity Investments, cutting an estimated $8.91M.

  • 115 institutional investors held Precision BioSciences (DTIL) as of Q2 2020, up from 109 in Q1 2020.
  • Funds reported $211M of Precision BioSciences stock for Q2 2020, up 33% quarter-over-quarter.
  • 22 funds opened new Precision BioSciences positions in Q2 2020 and 16 closed out, a net change of +6 holders.
  • The largest Precision BioSciences buyer in Q2 2020 was BlackRock, an estimated $5.26M added.
  • The largest Precision BioSciences seller in Q2 2020 was Fidelity Investments, an estimated $8.91M sold.

Based on aggregated 13F filings for Q2 2020.